Literature DB >> 17235680

Bi-directional electrical pulmonary vein isolation as an endpoint for ablation of paroxysmal atrial fibrillation.

Vidal Essebag1, John V Wylie, Matthew R Reynolds, Ferdinando Baldessin, Seth McClennen, Alexei Shvilkin, Joseph Germano, Allison Richardson, Peter J Zimetbaum, Mark E Josephson.   

Abstract

OBJECTIVE: Various approaches to pulmonary vein (PV) isolation have shown variable efficacy in patients with paroxysmal atrial fibrillation (AF). The purpose of this study is to report the efficacy and safety of routine isolation of all PVs using an endpoint of bi-directional electrical block.
MATERIALS AND METHODS: This study included 85 consecutive patients who underwent PV isolation for symptomatic paroxysmal AF. Complete isolation of all PVs was confirmed by demonstration of bi-directional block: (a) loss of all PV potentials, and (b) failure to capture the left atrium by pacing 10-14 bipolar pairs of electrodes on a circumferential catheter placed at the entrance of the PV at 10 mA with 2 ms pulse width. Induction of AF by burst pacing was attempted after PV isolation.
RESULTS: Freedom from symptomatic or asymptomatic AF (detected by event recorder or Holter monitor) was present in 85% and 76% of patients at 6 and 12 months. Additional mitral isthmus or posterior left atrial lines were performed in seven patients with inducible atrial arrhythmias after PV isolation. Atrial tachycardia occurred in three of these patients during long-term follow-up and in two of the 78 patients without additional ablation.
CONCLUSION: The use of bi-directional block circumferentially across all PV ostia as an electrophysiological endpoint may improve results of PV isolation for paroxysmal AF. Avoidance of routine additional left atrial ablation lines may decrease the risk of atrial tachycardia and esophageal fistula.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235680      PMCID: PMC1937574          DOI: 10.1007/s10840-006-9057-x

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  30 in total

1.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; S Garrigue; A Takahashi; T Lavergne; M Hocini; J T Peng; R Roudaut; J Clémenty
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

2.  Utility of exit block for identifying electrical isolation of the pulmonary veins.

Authors:  Edward P Gerstenfeld; Sanjay Dixit; David Callans; Robert Rho; Yadavendra Rajawat; Erica Zado; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2002-10

3.  Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation.

Authors:  C Pappone; S Rosanio; G Oreto; M Tocchi; F Gugliotta; G Vicedomini; A Salvati; C Dicandia; P Mazzone; V Santinelli; S Gulletta; S Chierchia
Journal:  Circulation       Date:  2000-11-21       Impact factor: 29.690

4.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

5.  Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation.

Authors:  Hakan Oral; Christoph Scharf; Aman Chugh; Burr Hall; Peter Cheung; Eric Good; Srikar Veerareddy; Frank Pelosi; Fred Morady
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

6.  Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies.

Authors:  Edward P Gerstenfeld; David J Callans; Sanjay Dixit; Erica Zado; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2003-07

7.  Efficacy and safety of targeted focal ablation versus PV isolation assisted by magnetic electroanatomic mapping.

Authors:  Francis E Marchlinski; David Callans; Sanjay Dixit; Edward P Gerstenfeld; Robert Rho; Jian-Fang Ren; Erica Zado
Journal:  J Cardiovasc Electrophysiol       Date:  2003-04

8.  Resumption of electrical conduction in previously isolated pulmonary veins: rationale for a different strategy?

Authors:  Kumaraswamy Nanthakumar; Vance J Plumb; Andrew E Epstein; George D Veenhuyzen; Dale Link; G Neal Kay
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

9.  Electrical connections between pulmonary veins: implication for ostial ablation of pulmonary veins in patients with paroxysmal atrial fibrillation.

Authors:  Atsushi Takahashi; Yoshito Iesaka; Yoshihide Takahashi; Ryoko Takahashi; Kenzaburo Kobayashi; Katsumasa Takagi; Osamu Kuboyama; Takeo Nishimori; Hidenobu Takei; Hiroshi Amemiya; Hideomi Fujiwara; Masayasu Hiraoka
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

10.  Reentrant tachycardia in pulmonary veins of patients with paroxysmal atrial fibrillation.

Authors:  Yoshihide Takahashi; Yoshito Iesaka; Atsushi Takahashi; Masahiko Goya; Kenzaburou Kobayashi; Hideomi Fujiwara; Masayasu Hiraoka
Journal:  J Cardiovasc Electrophysiol       Date:  2003-09
View more
  9 in total

1.  Pulmonary venous isolation versus additional substrate modification as treatment for paroxysmal atrial fibrillation.

Authors:  Andrew Robertson Gavin; Cameron B Singleton; John Bowyer; Andrew D McGavigan
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

2.  Mark E Josephson: Clinical Investigator.

Authors:  John M Miller
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-04

Review 3.  The Progressive Nature of Atrial Fibrillation:A Rationale for Early Restoration and Maintenance of Sinus Rhythm.

Authors:  Ashok J Shah; Meleze Hocini; Yuki Komatsu; Matthew Daly; Stephan Zellerhoff; Laurence Jesel; Sana Amaroui; Khaled Ramoul; Arnaud Denis; Nicolas Derval; Frederic Sacher; Pierre Jais; Michel Haissaguerre
Journal:  J Atr Fibrillation       Date:  2013-08-31

Review 4.  Surgical Ablation of Atrial Fibrillation: is Electrical Isolation of the Pulmonary Veins a Must?

Authors:  Bart Maesen; Ines Van-Loo; Laurent Pison; Mark La-Meir
Journal:  J Atr Fibrillation       Date:  2016-06-30

5.  Achieving Bidirectional Long Delays In Pulmonary Vein Antral Lines Prior To Bidirectional Block In Patients With Paroxysmal Atrial Fibrillation (The Bi-Bi Technique For Atrial Fibrillation Ablation).

Authors:  Adel F Mina; Nicholas L Warnecke
Journal:  J Atr Fibrillation       Date:  2016-08-31

6.  Inducibility of atrial fibrillation with a synchronized external low energy shock post-pulmonary vein isolation predicts recurrent atrial fibrillation.

Authors:  John V Wylie; Vidal Essebag; Matthew R Reynolds; Mark E Josephson
Journal:  J Cardiovasc Electrophysiol       Date:  2008-04-10

7.  Atrial tachycardias arising from ablation of atrial fibrillation: a proarrhythmic bump or an antiarrhythmic turn?

Authors:  Ashok J Shah; Amir Jadidi; Xingpeng Liu; Shinsuke Miyazaki; Andrei Forclaz; Isabelle Nault; Lena Rivard; Nick Linton; Olivier Xhaet; Nicolas Derval; Frederic Sacher; Pierre Bordachar; Philippe Ritter; Meleze Hocini; Pierre Jais; Michel Haissaguerre
Journal:  Cardiol Res Pract       Date:  2010-04-07       Impact factor: 1.866

8.  Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study.

Authors:  Dana C Peters; John V Wylie; Thomas H Hauser; Reza Nezafat; Yuchi Han; Jeong Joo Woo; Jason Taclas; Kraig V Kissinger; Beth Goddu; Mark E Josephson; Warren J Manning
Journal:  JACC Cardiovasc Imaging       Date:  2009-03

9.  Cardiovascular magnetic resonance imaging of scar development following pulmonary vein isolation: a prospective study.

Authors:  Jeff Hsing; Dana C Peters; Benjamin R Knowles; Warren J Manning; Mark E Josephson
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.